Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous ferric carboxymaltose versus oral ferrous sulphate for iron deficiency anaemia in pregnant women in Nigeria
ISRCTN63484804Phase 3Completed
- Sponsor
- University of Lagos
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in iron deficiency anemia (IDA) comparing Intravenous ferric carboxymaltose with Oral ferrous sulphate (2 arms). Primary endpoints: Prevalence of maternal anaemia at 36 weeks' gestation and Incidence of preterm birth. Started Aug 2021; status: completed.
02
Drugs
ferric carboxymaltoseferrous sulfate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on ISRCTN63484804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN63484804.